APP Abeta40 (Ponezumab biosimilar) Antibody from ABBEXA LTD

Search, find, compare suppliers for anti-APP Abeta40 (Ponezumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityAPP Abeta40 (Ponezumab biosimilar)
Clonemonoclonal
Host SpeciesRecombinant Human
Reactive Specieshuman
IsotypeIgG2 kappa
FormatProtein A/G purified
Size100 µg, 1 mg,
Concentrationtypically between 0.5-2.0 mg/ml.
ApplicationsELISA, WB
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionPonezumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting APP Abeta40, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Ponezumab is under investigation in clinical trial NCT00607308 (A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease).
Immunogenn/a
Other NamesPonezumab, APP Abeta40, 1178862-65-1
Gene, Accession #CAS: 1178862-65-1
Catalog #abx831216
Priceplease inquire
Order / More InfoAPP Abeta40 (Ponezumab biosimilar) Antibody from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.